Premium
Immunotherapy and the A2A Adenosine Receptor: A Confounding Brew
Author(s) -
Strohbehn Garth W.,
Ratain Mark J.
Publication year - 2019
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1428
Subject(s) - business , confounding , advisory committee , value (mathematics) , conflict of interest , medicine , family medicine , management , computer science , economics , finance , machine learning